Application of Animal Models in Diabetic Cardiomyopathy

Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunc...

Full description

Bibliographic Details
Main Authors: Wang-Soo Lee, Jaetaek Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2021-03-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:http://www.e-dmj.org/upload/pdf/dmj-2020-0285.pdf
id doaj-0043f149b06c4590a78fa8f410c7e6ae
record_format Article
spelling doaj-0043f149b06c4590a78fa8f410c7e6ae2021-04-02T01:07:41ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872021-03-0145212914510.4093/dmj.2020.02852538Application of Animal Models in Diabetic CardiomyopathyWang-Soo Lee0Jaetaek Kim1 Division of Cardiology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, KoreaDiabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets.http://www.e-dmj.org/upload/pdf/dmj-2020-0285.pdfcardiomyopathiesdiabetes mellitusdisease models, animalheart failure
collection DOAJ
language English
format Article
sources DOAJ
author Wang-Soo Lee
Jaetaek Kim
spellingShingle Wang-Soo Lee
Jaetaek Kim
Application of Animal Models in Diabetic Cardiomyopathy
Diabetes & Metabolism Journal
cardiomyopathies
diabetes mellitus
disease models, animal
heart failure
author_facet Wang-Soo Lee
Jaetaek Kim
author_sort Wang-Soo Lee
title Application of Animal Models in Diabetic Cardiomyopathy
title_short Application of Animal Models in Diabetic Cardiomyopathy
title_full Application of Animal Models in Diabetic Cardiomyopathy
title_fullStr Application of Animal Models in Diabetic Cardiomyopathy
title_full_unstemmed Application of Animal Models in Diabetic Cardiomyopathy
title_sort application of animal models in diabetic cardiomyopathy
publisher Korean Diabetes Association
series Diabetes & Metabolism Journal
issn 2233-6079
2233-6087
publishDate 2021-03-01
description Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets.
topic cardiomyopathies
diabetes mellitus
disease models, animal
heart failure
url http://www.e-dmj.org/upload/pdf/dmj-2020-0285.pdf
work_keys_str_mv AT wangsoolee applicationofanimalmodelsindiabeticcardiomyopathy
AT jaetaekkim applicationofanimalmodelsindiabeticcardiomyopathy
_version_ 1724175260402581504